Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Novel Device Detects COVID-19 Antibodies in Five Minutes

By LabMedica International staff writers
Posted on 30 Nov 2022

Rapid, cheap and accurate tests continue to be essential for epidemiological surveillance and for health services to monitor and contain the spread of SARS-CoV-2. A team of scientists has now developed an electrochemical immunosensor that detects antibodies against the virus.

In search of a novel diagnostic method, a group of scientists at the Federal University of the ABC (UFABC, São Paulo, Brazil) opted for a material frequently used in metallurgy – zinc oxide – and combined it for the first time with fluorine-doped tin oxide (FTO) glass, a conductive material used in electrodes for photovoltaics and other advanced applications. The electrode fabricated by the researchers detected COVID-19 antibodies in serum in about five minutes with 88.7% sensitivity and 100% specificity, outperforming even the enzyme-linked immunosorbent assay (ELISA) test, the current gold-standard clinical diagnostic tool. One of the advantages of the electrode they developed is its flexible architecture, which means that it can easily be customized for other diagnostic and biomedical applications using different biomolecules on the zinc oxide nanorods and other target analytes.

Prior knowledge of chemical properties such as the isoelectric point of the virus’s spike protein (S), enabled the group to develop a platform for S to bind electrostatically to zinc oxide nanorods. Zinc oxide is increasingly used to fabricate biosensors because of its versatility and unique chemical, optical and electrical properties. The immunosensor is easy to make and use, and its production cost is relatively low. The nanorods form a film on the FTO’s conductive surface, creating a favorable molecular microenvironment for immobilization of the S protein and making the construct a simple way to detect these antibodies. The researchers will now adapt the platform to make it portable and connectable to mobile devices for use in diagnosing COVID-19 and other infectious diseases.

“The technology is a versatile biosensing platform. As developed by us, it can be modified and customized for serological detection of other diseases of public health interest," said chemist Wendel Alves, lead author and a professor at the Center for Natural and Human Sciences, UFABC.

Related Links:
UFABC

Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.